Glucose tablets can help treat mild hypoglycemia when a person is awake, alert, and able to swallow. Many diabetes plans use the 15-15 approach: take about 15 grams of fast-acting carbohydrate, recheck glucose after 15 minutes, and repeat if still low. Severe symptoms need urgent medical help.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →What are glucose tablets used for in hypoglycemia?
Glucose tablets are used to raise low blood glucose quickly during non-severe hypoglycemia. They are most appropriate when the person can notice symptoms, check glucose if possible, chew and swallow safely, and follow their diabetes care plan.
What glucose tablets contain
Most glucose tablets contain dextrose, which is glucose. Glucose is the sugar your blood meter or continuous glucose monitor is estimating in the bloodstream. That is why oral glucose is a direct way to treat a low when swallowing is safe 4.
Why glucose works faster than mixed foods
Fast-acting carbohydrate is used because it can be absorbed more quickly than foods that contain fat, fiber, or a full meal. Chocolate, peanut butter, snack bars, or high-fiber foods may taste helpful, but they can slow sugar absorption when the goal is a faster glucose rise 3.
When tablets are appropriate and when they are not
Tablets fit mild or moderate lows when the person is awake and able to swallow. They are not the right tool for severe confusion, seizure, fainting, or inability to swallow. Those situations may require glucagon if prescribed and emergency help 4.
What does hypoglycemia feel like?
Hypoglycemia can feel like shakiness, sweating, hunger, anxiety, or a racing heartbeat. As glucose drops further, the brain may not get enough fuel, which can cause confusion, drowsiness, headache, trouble concentrating, or vision changes 4.
- Early warning signs may include shakiness, sweating, hunger, fast heartbeat, and feeling anxious.
- Brain-related symptoms may include confusion, trouble focusing, drowsiness, headache, blurred vision, or unusual behavior.
- Symptoms can vary by person and by situation. Exercise, sleep, alcohol, and recent insulin can change how a low feels 4.
- Hypoglycemia unawareness means a person has fewer warning symptoms before glucose becomes dangerously low. This needs clinician review because it raises safety risk 5.
If you are trying to understand your own numbers, our guides to blood sugar levels and diabetes and a normal blood sugar levels chart explain common ranges in more detail.
How many glucose tablets do people usually take for low blood sugar?
Many plans describe the 15-15 rule: about 15 grams of fast-acting carbohydrate, then recheck glucose after 15 minutes. The number of tablets depends on the grams of glucose listed on that product’s label, so tablet count is not the same for every brand 3.
This is not personal dosing advice. Children, people using insulin pumps, people who recently exercised, and people with repeated lows may need a different plan. A 2026 systematic review found that the best oral carbohydrate amount for non-severe hypoglycemia in type 1 diabetes can vary by the cause of the low and the insulin system used 3.
Guidelines for children and teens note that oral glucose around 0.3 g/kg can raise glucose by roughly 3 to 4 mmol/L, but this is a guidance statement, not a universal instruction for every person 4. Follow the plan your clinician gave you.
How much can glucose tablets raise blood sugar?
There is no single number that applies to everyone. A glucose response depends on body size, the starting glucose value, active insulin, recent exercise, alcohol, meal timing, and whether the person uses injections, a pump, or an automated insulin system 3.
In practice, the safest way to know whether glucose is rising is to recheck with a meter or follow CGM trend information when appropriate. A continuous glucose monitoring system can help show patterns, but finger-stick confirmation may still be needed when symptoms do not match the sensor reading.
Are glucose tablets better than juice, candy, or other sugars?
Glucose tablets have two practical strengths: the grams are clear on the label, and they are easy to carry. Juice, regular soda, candy, honey, or sugar can also raise glucose, but portions can be less exact and some foods are easier to overuse.
| Option | Why people use it | Trade-offs |
|---|---|---|
| Glucose tablets | Clear grams per tablet; portable; made for low glucose | Taste and chalky texture bother some people; must be able to chew and swallow |
| Glucose gel | Useful when chewing is hard but swallowing is still safe | Can be messy; still not for someone who cannot swallow safely |
| Juice | Easy to find; fast carbohydrate | Portion size matters; may be less portable |
| Regular soda | Fast carbohydrate if not diet soda | Easy to drink too much; carbonation may bother some people |
| Hard candy or jellybeans | Portable and familiar | Label reading is needed; choking risk if drowsy or confused |
| Honey, syrup, or sugar | Often available at home | Messy; portion can be unclear |
| Chocolate or snack bars | Commonly available | Fat and fiber may slow absorption, so they are not ideal for quick treatment |
A systematic review and meta-analysis found limited evidence that glucose tablets may relieve symptoms by 15 minutes more often than pooled dietary sugars, but the evidence base was small 1. The practical takeaway is simple: use a fast-acting carbohydrate with known grams, then recheck.
When is low blood sugar an emergency?
Severe hypoglycemia is an emergency when a person cannot safely self-treat. If there is seizure, fainting, severe confusion, inability to swallow, or a low that does not improve, oral glucose may not be safe and urgent care is needed 4.
- Do not put tablets, food, or liquid into the mouth of someone who is unconscious or unable to swallow safely.
- Use glucagon if it has been prescribed and you were trained to use it, then follow emergency instructions.
- Friends, family, coworkers, teachers, or exercise partners may need to know the person’s hypoglycemia plan.
- Recurrent lows should be reviewed with a clinician because the cause may be medication dose, meal timing, exercise, alcohol, illness, or impaired awareness 4.
What causes hypoglycemia in people with diabetes?
The most common drivers are diabetes medicines that can lower glucose too far, especially insulin and sulfonylureas. Missed or delayed meals, exercise, alcohol, illness, and changes in routine can also contribute 4.
Sulfonylureas, including glipizide, can cause hypoglycemia because they stimulate insulin release 6. If lows are happening often, the answer is not just to carry more sugar. The medication plan should be reviewed with a clinician.
A meter or CGM can help identify timing patterns. If your lows happen overnight, after workouts, after missed meals, or after medication changes, bring that pattern to your clinician. Our guide to glucose levels for type 2 diabetes explains how clinicians often think about glucose ranges over time.
Do GLP-1 medications like semaglutide or tirzepatide cause hypoglycemia?
Semaglutide and tirzepatide can affect glucose, but hypoglycemia risk depends on the full medication plan. Risk is especially important to review when GLP-1 or dual GIP/GLP-1 medicines are used with insulin or insulin-releasing drugs such as sulfonylureas.
Ozempic (semaglutide, a GLP-1 receptor agonist; also available as a compounded semaglutide formulation through licensed 503A pharmacies) labeling warns that hypoglycemia risk can increase when used with insulin secretagogues or insulin 7. Mounjaro and Zepbound (tirzepatide, a dual GIP/GLP-1 receptor agonist; also available as a compounded tirzepatide formulation through licensed 503A pharmacies) labeling includes similar hypoglycemia warnings when used with insulin secretagogues or insulin 8.
Side effects also matter. GLP-1 and dual GIP/GLP-1 medicines can cause nausea, vomiting, diarrhea, constipation, stomach pain, and reduced appetite, and they may not be appropriate for some people based on medical history. People with diabetes, recurrent lows, kidney disease risk from dehydration, or glucose-lowering medicines need individualized review before changing treatment.
3-min quiz
Considering weight-loss treatment with glucose safety in mind?
At Chia, our licensed providers review your health history, medications, and glucose-risk details before prescribing compounded semaglutide or compounded tirzepatide, when clinically appropriate. A prescription requires a medical evaluation and is not guaranteed. Compounded drugs are not FDA-approved.
How does Chia approach glucose-related safety questions during weight-loss care?
At Chia, glucose safety is part of the clinical review when a patient is considering weight-loss medication. We do not sell glucose tablets, insulin, sulfonylureas, or glucagon. We do offer clinician-reviewed compounded semaglutide injection and compounded tirzepatide tablets or injection when appropriate.
Chia’s semaglutide injection plans currently start at $249/month. Chia’s tirzepatide tablets and injections currently start at $249/month for tablets and $299/month for injections. Tirzepatide and semaglutide microdosing plans are available when a Chia provider decides that approach fits the patient’s goals and health history.
| Chia option | Forms Chia offers | Glucose-safety note |
|---|---|---|
| Compounded semaglutide | Injection; plans currently start at $249/month | Requires online intake and licensed provider review, especially if the patient uses insulin, sulfonylureas, or has recurrent lows |
| Compounded tirzepatide | Tablets from $249/month; injection from $299/month; microdosing plans available | Provider-guided dosing and follow-up are important for people with diabetes medicines or low-glucose history |
| Hypoglycemia rescue products | Not offered by Chia | Glucose tablets, glucagon, insulin, and sulfonylureas should be managed through the patient’s diabetes care clinician or local pharmacy |
Care starts with a short online questionnaire. A licensed US provider reviews it and prescribes only when clinically appropriate. If prescribed, medications are compounded in the US by state-licensed 503A pharmacies and shipped to the patient’s door. Patients can message the care team through the portal between visits.
What should you keep in a low-blood-sugar kit?
A low-blood-sugar kit should make the next step obvious when you feel shaky or foggy. Keep supplies where lows are most likely: your bag, car, bedside table, work desk, gym bag, or school bag.
- Fast-acting carbohydrate with clear grams per serving, such as glucose tablets or gel.
- A glucose meter, strips, lancets, or CGM supplies if you use them.
- Medical ID and emergency contacts.
- Glucagon if prescribed by your clinician, plus instructions for people around you.
- A written hypoglycemia plan, especially for school, work, travel, exercise, or overnight lows.
Which next step fits your situation?
The right next step depends on how low the glucose is, whether the person can swallow, and whether lows keep happening. Use this as a safety map, not as a replacement for your own diabetes plan.
| Situation | Sensible next step | Why |
|---|---|---|
| Awake, able to swallow, glucose near or below 70 mg/dL | Use the fast-acting carbohydrate plan your clinician gave you and recheck | This fits non-severe hypoglycemia guidance |
| Confused, very drowsy, seizing, fainted, or cannot swallow | Use prescribed glucagon if available and seek emergency help | Oral glucose can be unsafe when swallowing is impaired |
| Lows keep happening | Review insulin, sulfonylureas, meals, exercise, alcohol, and illness with a clinician | Repeated lows often mean the plan needs adjustment |
| Considering GLP-1 or tirzepatide while on diabetes medicines | Get individualized medication review before changing therapy | Hypoglycemia risk depends on the full treatment plan |
| Trying to understand glucose patterns | Use meter or CGM data and bring patterns to your clinician | Timing patterns can point to the cause |
When should you get help now?
Get help now for severe symptoms: seizure, fainting, inability to swallow, severe confusion, injury, or glucose that stays low despite following the person’s plan. If in doubt, treat it as urgent.
Also contact a clinician soon if lows are new, frequent, happening overnight, or occurring after medication changes. Do not stop or change insulin, sulfonylureas, GLP-1 medicines, or other diabetes treatments on your own.
3-min quiz
Start with a clinician-reviewed plan
If you are exploring weight-loss medication and have diabetes, low-glucose symptoms, or glucose-lowering prescriptions, Chia’s online visit helps our providers review whether compounded semaglutide or tirzepatide is clinically appropriate. A prescription is not guaranteed, and compounded drugs are not FDA-approved.
Yes. Glucose tablets can help mild or moderate hypoglycemia when the person is awake, alert, and able to swallow. They are not appropriate if the person is unconscious, seizing, severely confused, or unable to swallow.
It depends on the product. Some tablets contain different grams of glucose per tablet, so you need to read the label and follow your clinician’s hypoglycemia plan.
Many care plans advise rechecking glucose about 15 minutes after fast-acting carbohydrate. The actual response can vary based on active insulin, exercise, meal timing, alcohol, body size, and the cause of the low.
Candy can work if it contains fast-acting carbohydrate and you know the amount. Glucose tablets are often easier to measure. Chocolate and high-fat candy are not ideal for quick treatment because fat can slow absorption.
Some people may need a meal or snack after glucose returns to range, especially if the next meal is far away. Follow your clinician’s plan because needs differ by medication, activity, and timing.
Many plans advise repeating fast-acting carbohydrate and rechecking again. If glucose stays low, symptoms are severe, or the person cannot self-treat safely, seek emergency medical help.
No. If swallowing is not safe, do not use tablets, food, or drinks. Use prescribed glucagon if available and seek emergency help.
GLP-1 medications have a higher hypoglycemia concern when combined with insulin or medicines that increase insulin release, such as sulfonylureas. Compounded semaglutide and compounded tirzepatide are not FDA-approved, and people with diabetes or recurrent lows need individualized clinical review.
References
- 1.Carlson JN, Schunder-Tatzber S, Neilson CJ, Hood N. Dietary sugars versus glucose tablets for first-aid treatment of symptomatic hypoglycemia in awake patients with diabetes: a systematic review and meta-analysis. Emergency Medicine Journal. 2017;34(2):100-106.
- 2.Laugesen C, Ranjan AG, Schmidt S, et al. Low-Dose Dasiglucagon Versus Oral Glucose for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes: A Phase 2, Randomized, Three-Arm Crossover Study. Diabetes Care. 2022.
- 3.Prince NL, Lochnan HA, Shorr R, Garon-Mailer A, Sun CJ. Systematic Review of Oral Carbohydrate Treatment for Non-Severe Hypoglycemia in Type 1 Diabetes: A Comparison of Insulin Management Systems. Diabetes, Metabolic Syndrome and Obesity. 2026;19.
- 4.Abraham MB, Jones TW, Naranjo D, et al. ISPAD Clinical Practice Consensus Guidelines 2022: Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatric Diabetes. 2022.
- 5.Garg SK, Brazg RL, Bailey TS, et al. The Need to Change Regulatory Evaluation of Hypoglycemia Prevention and Management in Diabetes. Journal of Diabetes Science and Technology. 2020.
- 6.Correa R, Farooq U. Glipizide. StatPearls. 2024.
- 7.U.S. Food and Drug Administration. Ozempic (semaglutide) injection prescribing information. 2025.
- 8.U.S. Food and Drug Administration. Mounjaro (tirzepatide) injection prescribing information. 2025.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



